Pediatrix Medical GroupFRA:PDC +2.78%59 Buyback Yield % is 4.82 as of Jul. 02, 2026, which is 599% above its 10-year median of 0.69. GuruFocus rates FRA:PDC with a GF Score™ of 59/100 and a GF Value™ of €11.16 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 272 Healthcare Providers & Services companies, Pediatrix Medical Group ranks better than 90.81% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PDC vs SEM, AGL, SGRY: Buyback Yield % Comparison
For the Medical Care Facilities subindustry, Pediatrix Medical Group's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pediatrix Medical Group Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Pediatrix Medical Group's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pediatrix Medical Group (FRA:PDC) has a Buyback Yield % of 4.82 as of Jul. 02, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Pediatrix Medical Group and its competitors. This is 599% above median its historical median of 0.69. According to the industry distribution chart, Pediatrix Medical Group ranks #25 out of 272 companies in the Healthcare Providers & Services industry, placing it in the top 9.2%.
Is Pediatrix Medical Group's Buyback Yield % too high?
Pediatrix Medical Group's current Buyback Yield % of 4.82 is 599% above median its 10-year median of 0.69. Based on the distribution chart, Pediatrix Medical Group ranks #25 out of 272 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Pediatrix Medical Group has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's Buyback Yield % compare to SEM and AGL?
According to the Healthcare Providers & Services industry distribution chart, Pediatrix Medical Group ranks #25 out of 272 companies for Buyback Yield %. This places Pediatrix Medical Group in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Pediatrix Medical Group and its competitors. Pediatrix Medical Group's current Buyback Yield % is 4.82, which is 599% above median its own 10-year median of 0.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Pediatrix Medical Group (FRA:PDC) is currently considered Significantly Overvalued. The stock's GF Value™ is €11.16, compared to a current price of €22.20 — trading 98.9% above its estimated fair value. The current Buyback Yield % is 4.82, which is 599% above median its 10-year median of 0.69. Pediatrix Medical Group's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Pediatrix Medical Group (FRA:PDC), the current Buyback Yield % is 4.82 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pediatrix Medical Group (FRA:PDC) Overvalued in 2026?
Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued.
The current stock price of €22.20 is trading 98.9% above its estimated GF Value™ of €11.16.
GuruFocus considers Pediatrix Medical Group to be Significantly Overvalued.
Key valuation signals for FRA:PDC:
Buyback Yield %: 4.82 (599% above median its 10-year median of 0.69)
GF Value™: €11.16 vs. price of €22.20 (98.9% above fair value)
No single metric tells the full story. See the FRA:PDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
59GF Score
Get the complete analysis for FRA:PDC
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PDC has been successfully added to your 
